Key points are not available for this paper at this time.
The incidence of and mortality from invasive melanoma in the United States has risen steadily for at least the past 2 decades. 1 Similar trends are being seen worldwide despite numerous efforts to enhance primary prevention and early detection, and these increasing rates are having an impact on the public health and economic burden of disease. In 2009, we reported on the status of US melanoma incidence at that time.
Glazer et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: